Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
07.01. | Bio-Rad Expands Chromatography Columns for Biotherapeutic Production | ||
07.01. | Merck KGaA Adopts Bio-AI Clinical Prediction Platform | ||
07.01. | Orbis Medicines Gets Funding to Develop Pipeline of Oral Macrocycles | ||
07.01. | Lifecore Biomedical Sells Excess Capital Equipment for $17M | ||
07.01. | Molex Closes Acquisition of Vectura Group | ||
07.01. | ProBioGen Expands Protein & Virus Manufacturing at Its Berlin HQ | ||
06.01. | Cryoport's MVE Biological Solutions Registers Mfg. Facilities with FDA | ||
06.01. | Platinum Press Inc. Completes $15M Expansion in Fort Worth, TX | ||
06.01. | WuXi Biologics to Sell Vaccine Facility in Ireland to Merck for $500M | ||
06.01. | LPOXY Therapeutics Acquires Assets from Xeno Biosciences | ||
06.01. | Sentnyl's NDA for CUTX-101 Accepted by FDA for Filing and Priority Review | ||
20.12.24 | Neurocrine Bioscience's CRENESSITY Becomes Commercially Available in the U.S. | ||
19.12.24 | PTC Therapeutics Submits Vantiquinone NDA to FDA | ||
19.12.24 | Lifecore Biomedical to Provide CDMO Services to Nirsum Labs | ||
19.12.24 | Photys, Novo Nordisk Ink Cardiometabolic Research Pact | ||
18.12.24 | Trodelvy Granted FDA Breakthrough Therapy Designation | ||
18.12.24 | Novo Holdings Completes Acquisition of Catalent | ||
18.12.24 | Merck Enters Exclusive Alliance with Hansoh Pharma for Oral GLP-1 Candidate | ||
18.12.24 | Adicet Bio Names Dr. Julia Maltzman as Chief Medical Officer | ||
18.12.24 | Juncell Therapeutics Opens New TIL Manufacturing Facility | ||
18.12.24 | Samsung Invests in Generate: Biomedicines | ||
17.12.24 | Great Bay Bio Secures Series B Funding to Fuel Global Expansion | ||
17.12.24 | Fresenius Kabi Launches Generic Epinephrine Injection in U.S. | ||
17.12.24 | BioVaxys Acquires Critical Lipid Supply for DPX Platform | ||
17.12.24 | Alphina Therapeutics Appoints Chief Scientific Officer |